R&D
Search documents
Novartis CEO on Q2 earnings beat and patent expiries
CNBC Television· 2026-07-21 21:00
Yeah, I think when we looked at it and we looked at the opportunities that we have to continue to invest in R&D, we had some cost phasing as well, we thought the prudent approach for now, especially in a year where we face so many generic expertise uh was to hold the guidance where it is, continue to invest in the pipeline. I mean really the story for us goes into the second half where we have six major readouts, pipeline readouts, uh which could really reshape uh the future of the of the company and allow ...